ElsaLys Biotech

About:

ElsaLys Biotech is a France-based developer of therapeutic monoclonal antibodies.

Website: http://www.elsalysbiotech.com

Top Investors: Transgene, Sofimac Investment Managers

Description:

ElsaLys Biotech, a Lyon & Illkirch Graffenstaden-France-based developer of therapeutic monoclonal antibodies, raised €2.1m in its first round of financing.

Total Funding Amount:

2.1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lyon, Rhone-Alpes, France

Founded Date:

2013-01-01

Founders:

Christine Guillen, Thierry Menguy, Vanessa Duong

Number of Employees:

11-50

Last Funding Date:

2013-05-17

IPO Status:

Private

Industries: